The International Association of Athletics Federations (IAAF) will insist that South African Olympic champion and intersex athlete, Caster Semenya should be classified as a ‘biological male’ at a Court of Arbitration of Sports hearing next week.
According to The Times, lawyers for the athletics’ international body
will argue that the 28-year-old South African should be allowed to
compete in women’s events if, as transgender athletes do, she takes
testosterone suppressants.
The hearing, which is set to last five days, is concerning Semenya
and athletes with ‘differences of sexual development’ (DSD) and is
likely to have a huge impact for transgender athletes in women’s
categories, the publication added.
The move is expected to divide views over whether Semenya and other
DSD runners should be forced to take testosterone blockers, usually a
contraceptive pill.
According to Mail Online, the result of the 800m final at the Rio
2016 Olympics summed up the complexity of the issue. As well as race
winner Semenya, silver medallist Francine Niyonsaba of Burundi and
bronze medallists Margaret Wambui of Kenya, have also faced questions
about their testosterone levels
Speaking to The Times on the case, Jonathan Taylor,
the IAAF’s London-based lawyer from the firm Bird & Bird, said: ‘If
the CAS rules that legal recognition as female is sufficient to qualify
for the female category of competition, and the IAAF is not permitted to
require athletes of female legal sex who have testes and consequently
male levels of testosterone to reduce those levels down to the female
range, then DSD and transgender athletes will dominate the podiums and
prize money in sport, and women with normal female testosterone levels
will not have any chance to win
